Aurobindo Pharma transferring domestic branded generic business to subsidiary Auropharm for ₹143 cr
The move is in line with the strategy to further streamline and accelerate the company’s domestic business for faster growth, Aurobindo Pharma said
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.